Dimensional Fund Advisors’s INmune Bio INMB Stock Holding History

Dimensional Fund Advisors’s Portfolio INMB Stock Details INMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$45K	Buy	23,075 +12,494	+118%	+$25.7K	﹤0.01%	3198
2026 Q2	$17.2K	Hold	10,581	–	–	﹤0.01%	3215
2026 Q1	$12K	Hold	10,581	–	–	﹤0.01%	3213
2025 Q4	$16.5K	Hold	10,581	–	–	﹤0.01%	3239
2025 Q3	$21.9K	Sell	10,581 -14,558	-58%	-$33.3K	﹤0.01%	3266
2025 Q2	$58.1K	Hold	25,139	–	–	﹤0.01%	3227
2025 Q1	$196K	Hold	25,139	–	–	﹤0.01%	3132
2024 Q4	$117K	Buy	25,139 +10,491	+72%	+$54.7K	﹤0.01%	3227
2024 Q3	$79K	Buy	+14,648	New	+$104K	﹤0.01%	3256
2022 Q1	–	Sell	-11,052	Closed	-$113K	–	3532
2021 Q4	$113K	Hold	11,052	–	–	﹤0.01%	3422
2021 Q3	$215K	Hold	11,052	–	–	﹤0.01%	3337
2021 Q2	$194K	Hold	11,052	–	–	﹤0.01%	3341
2021 Q1	$131K	Hold	11,052	–	–	﹤0.01%	3327
2020 Q4	$190K	Sell	11,052 -4,976	-31%	-$46.9K	﹤0.01%	3229
2020 Q3	$165K	Buy	+16,028	New	+$163K	﹤0.01%	3221

Other funds holding INMB

Westside Investment Management Santa Monica, California $785M AUM 29.89% 1-Year Est. Return

Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Modera Wealth Management Westwood, New Jersey $9.5B AUM 16% 1-Year Est. Return

Bill Few Associates Pittsburgh, Pennsylvania $485M AUM 17.8% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Leonteq Securities AG Zurich, Switzerland $2.44B AUM 50.17% 1-Year Est. Return

Close Asset Management London, United Kingdom $3.42B AUM 34.5% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Dimensional Fund Advisors's INMB Position: Q3 2026 in Review

Dimensional Fund Advisors increased its INmune Bio (INMB) stake by 118% in Q3 2026, buying an estimated $25.7K and bringing the position to 23,075 shares worth $45K. The position accounts for ﹤0.01% of the portfolio, ranked #3198.

Dimensional Fund Advisors first reported a position in INMB in Q3 2020 and has held it in 15 quarters since. The position peaked at $215K in Q3 2021. 15 funds tracked by Wall St. Rank hold INMB as of Q3 2026.

Dimensional Fund Advisors held 23,075 shares of INmune Bio worth $45K as of Q3 2026.
Dimensional Fund Advisors bought 12,494 INmune Bio shares in Q3 2026, an estimated $25.7K.
INmune Bio made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #3198 holding.
Dimensional Fund Advisors first reported a position in INmune Bio in Q3 2020 and has held it in 15 quarters since.
Dimensional Fund Advisors's INmune Bio position peaked at $215K in Q3 2021.
15 funds tracked by Wall St. Rank held INmune Bio as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.